More than one-third of German patients with systemic lupus erythematosus (SLE) did not get vaccinated, largely due to fear of…
Iqra Mumal, MSc
Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Iqra Mumal, MSc
A combination treatment of bisphosphonate and vitamin D may prevent cardiovascular disease in patients with systemic lupus erythematosus (SLE), a new…
Women with lupus nephritis — an inflammation of the kidneys caused by lupus — are at increased risk for…
A new test looking at the presence of 26 autoantibodies — antibodies targeting a person’s own healthy proteins — is…
Treatment with atacicept — a protein that targets the immune system — significantly reduced disease flares in patients with…
Native American patients are diagnosed with systemic lupus erythematosus (SLE) at an earlier age and present with worse concurrent rheumatic…
Pulmonary manifestations, specifically interstitial lung disease (ILD) and serositis — inflammation of tissues lining the lungs — are more common…
Long-term use of Benlysta (belimumab), an approved therapy, is both safe and effective, reducing disease activity in most systemic lupus…
Environmental factors, including UV light and air pollution, can significantly contribute to the development or progression of systemic lupus erythematosus…
Patients with lupus found the Patient Reported Outcomes Measurement Information System (PROMIS) assessment tool to be relevant, valuable, and useful…